Holdings

Symbol Grade Price % Change Allocation
GSK A -0.07 0.97
NVS B -0.57 0.83
STLA D 1.78 0.79
RDY C -0.11 0.61
SMFG D 1.13 0.57
MFG D 1.25 0.57
NOK B 0.00 0.54
SKM D -0.47 0.53
HMC D 1.62 0.52
KT D 0.68 0.50
KOF B -1.11 0.49
AZN A 0.46 0.39
UMC C -0.12 0.21
INFY D -0.23 0.16
VALE C 0.16 0.13
MUFG D 1.00 0.12
LYG A -0.72 0.12
BP C 0.82 0.09
TD F 2.82 0.07
BWLP B 6.38 0.07
GFI B 1.71 0.05
AKO.A B -0.21 0.04
GGB C 1.98 0.03
FMX D -0.53 0.02
TSM B 1.85 0.01
CHKP D 0.60 0.00

Recent News for Hartford Multifactor Diversified International ETF & its Holdings

Date Stock Title
May 27 TSM 2 Growth Stocks With Great Potential in 2024 and Beyond
May 27 TSM Taiwan Semiconductor Manufacturing Company Limited (TSM) Rose on Investors Optimism on Cyclical Recovery
May 27 STLA Stellantis Plans To Build Two More Hybrid Vehicles In Italy Amid Political Tensions: Report
May 27 TSM 5 Stocks Likely to Gain on NVIDIA's Blockbuster Q1 Results
May 27 GSK AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
May 27 AZN AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
May 27 TSM TSMC Rally May Extend as Foreign Ownership Still Far From Record
May 27 TSM TSMC’s Foreign Investments Are Good for Taiwan, Official Says
May 26 TSM What's New In Consumer Tech World Last Week? News That You Should Know (May 19-May 25)
May 26 AZN Wall Street Breakfast: The Week Ahead
May 25 TSM Is Taiwan Semiconductor Manufacturing Company (NYSE:TSM) the Most Unstoppable AI Stock to Buy Now?
May 25 TD Toronto-Dominion Bank Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 25 NVS Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
May 25 NVS Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
May 25 TSM Is It Time to Dump Nvidia Stock for Advanced Micro Devices After Microsoft Announcement?
May 24 TSM TSMC (TSM) Outperforms Broader Market: What You Need to Know
May 24 GSK Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit
May 24 NOK Nokia Corporation: Repurchase of own shares on 24.05.2024
May 24 TSM Taiwan Semi Leads While China's SMIC Climbs to Third in Global Chip Market
May 24 NVS After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
The investment seeks to provide investment results that correspond to the total return performance of the Hartford Multifactor Diversified International Index. The fund generally invests at least 80% of its assets in the equity securities that are components of the index and in depositary receipts (such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs)) representing securities of the index. The index is designed to enhance return potential available from investment in a capitalization-weighted universe of developed and emerging markets located outside the U.S.
American Depositary Receipt Global Depository Receipt Specialized Investment Fund The Hartford European Depositary Receipt
Back to the Main RODE Page...